Shanghai Ruotuo Biotechnology Co., Ltd. announced that it has received an equity round of funding on November 20, 2023. The transaction included participation from new investor, Shanghai Junshi Biosciences Co., Ltd. along with angel investors for 48.9990% stake. The company's registered capital has increased from CNY 3 million to CNY 5.88220 million post-completion of the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.74 HKD | +4.88% | +16.23% | -44.75% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.75% | 3.18B | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.35B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- 1877 Stock
- News Shanghai Junshi Biosciences Co., Ltd.
- Shanghai Ruotuo Biotechnology Co., Ltd. announced that it has received equity funding from Shanghai Junshi Biosciences Co., Ltd. and other investors.